Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia

Health and Quality of Life Outcomes

Paul F M Krabbe³  MarcelGMOlde Rikkert⁴  Joost J G Wammes²  Alexander M M Arons¹  Carla J M Schölzel-Dorenbos⁵ 

[1] Dept. of Epidemiology, Biostatistics & HTA, Radboud University Medical Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands;Department of Epidemiology, Biostatistics & HTA, Radboud University Medical Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands;Department of Epidemiology, University of Groningen University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands;Alzheimer Center Nijmegen, Dept. of Geriatrics, Radboud University Medical Centre, 925 Geriatrics, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands;Multidisciplinary Memory Clinic Slingeland Hospital/Alzheimer Centre Nijmegen, Radboud University Nijmegen Medical Centre, Kruisbergseweg 25, Doetinchem, 7009 BL, The Netherlands

关键词: Cost-effectiveness;    Disease-specific index instrument;    Dementia Quality of life Instrument (DQI);    Health-related quality of life;    Dementia;   

Others  :  825075
DOI  :  10.1186/1477-7525-10-118

 received in 2012-01-11, accepted in 2012-07-26,  发布年份 2012

【 摘 要 】

Background

Index measures for health-related quality of life (HRQoL) quantify the desirability (utility) of a certain health state. The commonly used generic index measure, e.g. EuroQol: EQ-5D, may underestimate relevant areas of specific diseases, resulting in lower validity. Disease-specific index measures on the other hand combine disease-specificity and quantification of perceived quality on several health domains of a certain disease into one single figure. These instruments have been developed for several diseases, but a dementia-specific HRQoL index instrument was not yet available. Facing the increasing individual and societal burden of dementia, specific HRQoL values with metric characteristics are especially useful because they will provide vital information for health outcome research and economic evaluations.

Aims of the study

To develop and validate the prototype of a dementia-specific HRQoL index measure: Dementia Quality of life Instrument (DQI), as the first step towards valuation of the dementia health state.

Methods

For development of the DQI we created a conceptual framework based on a review of the literature, qualitative interviews with people with dementia and their carers, expert opinion and team discussion. To assess validity we undertook a survey under 241 dementia professionals. Measurements consisted of ranking (1–5) and rating (1–10) of 5 dementia-specific DQI domains (memory, orientation, independence, social activities and mood) and simultaneously rating of 9 DQI-derived health states on a visual analogue scale (VAS). We also performed a cross-sectional study in a large sample of people with very mild to moderate dementia and their caregivers (N = 145) to assess feasibility and concurrent validity. In addition, caregivers valued 10 DQI and 10 EQ-5D + C derived health states of the patient simultaneously on the same VAS. Setting: outpatient clinics, nursing homes and patient residences.

Results

All professionals judged the selected DQI domains to be relevant. Differences in ranking and rating behaviors were small. Mood was ranked (≥3.3) and rated (≥8.2) as most, orientation as least important (rank ≤2.6, value 7.5) health domain for dementia. For the validation part of this study the completion rates for all domains were above 98% for patients and 100% for caregivers on patients. A priori hypothesized DQI versus QOL-AD correlations that were significant in both patients and caregivers were: memory/memory, orientation/memory, independence/physical health, social activities/energy and mood/mood. Patient/caregiver inter-rater agreement was low (K < 0.2) for memory/independence, fair (K 0.2-0.4) for orientation/mood, and moderate (K 0.4-0.6) for social activities. Concurrent validity of the DQI with the EQ-5D + C was moderate. The fact that most of the correlations between the domains of these two instruments were low (≤0.40) showed that both instruments measure different elements of health status. As expected, modest correlations (≥0.40) were observed between corresponding domains of the two instruments.

Conclusions

Professionals judged all domains as relevant. The DQI prototype proved valid and feasible for patients and caregivers and is appropriate for very mild to moderate dementia. The differences in concurrent correlations with generic health status instruments imply that the dementia-specific DQI health domains indeed provide different information. The finding that patient HRQoL measured with the DQI was lower supports this notion. The new DQI shows comparable psychometric properties to the best available dementia-specific (QOL-AD) and generic (EQ-5D + C) measures. Further research is needed to generate values in the general population for each of the possible DQI states and to derive an algorithm that converts the 5 separate DQI domain scores into one single DQI Index score. Introducing the DQI Index will advance dementia-related HRQoL measurement by overcoming the shortcomings of generic and non-index instruments. This will allow more unequivocal interpretation of subjective dementia HRQoL states in dementia research.

【 授权许可】

   
2012 Schölzel-Dorenbos et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Trial designs and outcomes in dementia therapeutic research. London and New York: Taylor & Francis Group; 2006.
• [2]Banerjee S, Samsi K, Petrie CD, et al.: What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia. Int J Geriatr Psychiatry 2009, 24:15-24.
• [3]Schölzel-Dorenbos CJM, Krabbe PFM, Olde Rikkert MGM: Quality of life in dementia patients and their proxies; a narrative review of the concept and measurement scales. In Handbook of Disease Burdens and Quality of Life Measures. Edited by Preedy VR, Watson RR. Heidelberg, Germany: Springer; 2010:3671-3691.
• [4]Fanshel S, Bush JW: A Health-Status Index and its application to health-services outcomes. Oper Res 1970, 18:1021-1066.
• [5]Langenhoff BS, Krabbe PF, Wobbes T, Ruers TJ: Quality of life as an outcome measure in surgical oncology. Br J Surg 2001, 88:643-652.
• [6]Streiner DL, Norman GR: Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 2008.
• [7]Ware JE Jr: Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
• [8]Brod M, Stewart AL, Sands L, Walton P: Conceptualization and measurement of quality of life in dementia: the dementia quality of life instrument (DQoL). Gerontologist 1999, 39:25-35.
• [9]Logsdon RG, Gibbons LE, McCurry SM, Teri L: Assessing quality of life in older adults with cognitive impairment. Psychosom Med 2002, 64:510-519.
• [10]Krabbe PF: Thurstone scaling as a measurement method to quantify subjective health outcomes. Med Care 2008, 46:357-365.
• [11]Brooks R: EuroQol: the current state of play. Health Policy 1996, 37:53-72.
• [12]Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33:337-343.
• [13]Riepe MW, Mittendorf T, Forstl H, et al.: Quality of life as an outcome in Alzheimer’s disease and other dementias - obstacles and goals. BMC Neurol 2009, 9:47-69.
• [14]Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E: International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. Int Psychogeriatr 2007, 19:345-354.
• [15]Buxton MJ, Lacey LA, Feagan BG, Niecko T, Miller DW, Townsend RJ: Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn’s Disease Activity Index in Crohn’s disease and measures of utility. Value Health 2007, 10:214-220.
• [16]Kirsch J, McGuire A: Establishing health state valuations for disease specific states: an example from heart disease. Health Econ 2000, 9:149-158.
• [17]Lenert LA, Rupnow MF, Elnitsky C: Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia. Health Qual Life Outcomes 2005, 3:57.
• [18]Peacock S, Misajon R, Iezzi A, Richardson J, Hawthorne G, Keeffe J: Vision and quality of life: development of methods for the VisQoL vision-related utility instrument. Ophthalmic Epidemiol 2008, 15:218-223.
• [19]Wasserman J, Aday LA, Begley CE, Ahn C, Lairson DR: Measuring health state preferences for hemophilia: development of a disease-specific utility instrument. Haemophilia 2005, 11:49-57.
• [20]Cook DA, Beckman TJ: Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med 2006, 119:166-16.
• [21]Schölzel-Dorenbos CJM, Ettema TP, Bos J, et al.: Evaluating the outcome of interventions on quality of life in dementia: selection of the appropriate scale. Int J Geriatr Psychiatry 2007, 22:511-519.
• [22]Meeuwsen EJ, Melis RJ, Adang EM, et al.: Cost-effectiveness of post-diagnosis treatment in dementia coordinated by multidisciplinary memory clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial. J Nutr Health Aging 2009, 13:242-248.
• [23]American Psychiatric Association: DSM-IV-TR. Diagnostic and Statistical Manual of Mental disorders. Fourth edition edition. Washington DC: American Psychiatric Association; 2000.
• [24]Morris JC: Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997, 9:173-176.
• [25]Hoeymans N, van Lindert H, Westert GP: The health status of the Dutch population as assessed by the EQ-6D. Qual Life Res 2005, 14:655-663.
• [26]Krabbe PF, Stouthard ME, Essink-Bot ML, Bonsel GJ: The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol 1999, 52:293-301.
• [27]Wolfs CA, Dirksen CD, Kessels A, Willems DC, Verhey FR, Severens JL: Performance of the EQ-5D and the EQ-5D + C in elderly patients with cognitive impairments. Health Qual Life Outcomes 2007, 5:33-43.
• [28]Coucill W, Bryan S, Bentham P, Buckley A, Laight A: EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care 2001, 39:760-771.
• [29]Naglie G, Tomlinson G, Tansey C, et al.: Utility-based quality of life measures in Alzheimer’s disease. Qual Life Res 2006, 15:631-643.
• [30]van der Wal W, Moorer P, Wolffensperger EW: GINO Zorgzwaarteschalen, een intersectorale AWBZ-brede zorgzwaartemeting op basis van de Landelijke Formulierenset CIZ. Groningen, GINO: Ongepubliceerd manuscript; 2005.
• [31]Kaufer DI, Cummings JL, Ketchel P, et al.: Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000, 12:233-239.
• [32]Dröes R-M, Boelens ECC, Bos J, et al.: Quality of life in dementia in perspective; an explorative study of variations in opinions among people with dementia and their professional caregivers, and in literature. Dementia: Int J Social Research and Practice 2006, 5:533-558.
• [33]Gerritsen DL, Ettema TP, Boelens E, et al.: Quality of life in dementia: do professional caregivers focus on the significant domains? Am J Alzheimers Dis Other Demen 2007, 22:176-183.
• [34]Reisberg B, Ferris SH, de Leon MJ, Crook T: Global Deterioration Scale (GDS). Psychopharmacol Bull 1988, 24:661-663.
• [35]Wilkin D, Mashiah T, Jolley DJ: Changes in behavioural characteristics of elderly populations of local authority homes and long-stay hospital wards, 1976–7. Br Med J 1978, 2:1274-1276.
• [36]Rockwood K, Howlett S, Stadnyk K, Carver D, Powell C, Stolee P: Responsiveness of goal attainment scaling in a randomized controlled trial of comprehensive geriatric assessment. J Clin Epidemiol 2003, 56:736-743.
• [37]Lawton MP: The Philadelphia Geriatric Center Morale Scale: a revision. J Gerontol 1975, 30:85-89.
• [38]Smith SC, Murray J, Banerjee S, et al.: What constitutes health-related quality of life in dementia? Development of a conceptual framework for people with dementia and their carers. Int J Geriatr Psychiatry 2005, 20:889-895.
• [39]The EuroQol Group (no authors listed): EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
• [40]CIBIS: CIBIS (Clinician Interview Based Impression of Severity). http://www.pfizer.com.au/Conditions/CIBIS_CIBIC.pdf webcite. 2010. Ref Type: Electronic Citation
• [41]Teunisse S, Derix MM: The interview for deterioration in daily living activities in dementia: agreement between primary and secondary caregivers. Int Psychogeriatr 1997, 9(Suppl 1):155-162.